Emergence of plasmid-mediated quinolone resistance genes in clinical isolates of Acinetobacter baumannii and Pseudomonas aeruginosa in Henan, China

Diagnostic Microbiology and Infectious Disease

Volumn 79, Issue 3, 2014, Pages 381-383

  Jiang, Xiaobing ^a   Yu, Tao ^b   Jiang, Xiaojie ^c   Zhang, Wei ^b   Zhang, Laiping ^b   Ma, Jianmin ^a  

^a HENAN NORMAL UNIVERSITY   (China)

^b XINXIANG UNIVERSITY   (China)

^c ZHENGZHOU UNIVERSITY   (China)

Author keywords

Acinetobacter baumannii; PMQR; Pseudomonas aeruginosa; QRDRs

Indexed keywords

BETA LACTAMASE; BETA LACTAMASE CTX M; BETA LACTAMASE PER; BETA LACTAMASE SHV; BETA LACTAMASE TEM 1; CIPROFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SODIUM AZIDE; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; QUINOLONE DERIVATIVE;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIAL MUTATION; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CHINA; DNA SEQUENCE; GENE FREQUENCY; GENETIC RESISTANCE; GENETIC VARIABILITY; MUTATIONAL ANALYSIS; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; QEPA GENE; QNRA GENE; QNRB GENE; QNRB4 GENE; QNRC GENE; QNRD GENE; QNRS GENE; QNRS1 GENE; ACINETOBACTER INFECTION; DRUG EFFECTS; GENERAL HOSPITAL; GENETICS; HUMAN; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; PLASMID; PSEUDOMONAS INFECTION;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; CHINA; DRUG RESISTANCE, BACTERIAL; GENES, BACTERIAL; HOSPITALS, GENERAL; HUMANS; MICROBIAL SENSITIVITY TESTS; PLASMIDS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; QUINOLONES;

EID: 84902106235     PISSN: 07328893     EISSN: 18790070     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2014.03.025     Document Type: Article

References (18)

1. Akasaka T., Tanaka M., Yamaguchi A., Sato K. Type II topoisomerase mutations in fluoroquinolone-resistant clinical strains of Pseudomonas aeruginosa isolated in 1998 and 1999: role of target enzyme in mechanism of fluoroquinolone resistance. Antimicrob Agents Chemother 2001, 45:2263-2268.
2. Bonomo R.A., Szabo D. Mechanisms of multidrug resistance in Acinetobacter species and Pseudomonas aeruginosa. Clin Infect Dis 2006, 43:S49-S56.
3. Cavaco L.M., Hasman H., Xia S., Aarestrup F.M. qnrD, a novel gene conferring transferable quinolone resistance in Salmonella enterica serovar Kentucky and Bovis morbificans strains of human origin. Antimicrob Agents Chemother 2009, 53:603-608.
4. Clinical and Laboratory Standards Institute (CLSI) Performance standards for antimicrobial susceptibility testing: 20th information supplement (M100-S20) 2010, CLSI, Wayne, PA.
5. Glupczynski Y., Bogaerts P., Deplano A., Berhin C., Huang T.D., Van Eldere J., et al. Detection and characterization of class A extended-spectrum-β-lactamase-producing Pseudomonas aeruginosa isolates in Belgian hospitals. J Antimicrob Chemother 2010, 65:866-871.
6. Hujer K.M., Hujer A.M., Endimiani A., Thomson J.M., Adams M.D., Goglin K., et al. Rapid determination of quinolone resistance in Acinetobacter spp. J Clin Microbiol 2009, 47:1436-1442.
7. Jiang Y., Zhou Z., Qian Y., Wei Z., Yu Y., Hu S., et al. Plasmid-mediated quinolone resistance determinants qnr and aac(6')-Ib-cr in extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae in China. J Antimicrob Chemother 2008, 61:1003-1006.
8. Martínez-Martínez L., Pascual A., Jacoby G.A. Quinolone resistance from a transferable plasmid. Lancet 1998, 351:797-799.
9. Ogbolu D.O., Daini O.A., Ogunledun A., Alli A.O., Webber M.A. High levels of multidrug resistance in clinical isolates of Gram-negative pathogens from Nigeria. Int J Antimicrob Agents 2011, 37:62-66.
10. Poirel L., Karim A., Mercat A., Le Thomas I., Vahaboglu H., Richard C., et al. Extended-spectrum β-lactamase-producing strain of Acinetobacter baumannii isolated from a patient in France. J Antimicrob Chemother 1999, 43:157-158.
11. Rodríguez-Martínez J.M., Cano M.E., Velasco C., Martínez-Martínez L., Pascual Á. Plasmid-mediated quinolone resistance: an update. J Infect Chemother 2011, 17:149-182.
12. Wang M., Tran J.H., Jacoby G.A., Zhang Y., Wang F., Hooper D.C. Plasmid-mediated quinolone resistance in clinical isolates of Escherichia coli from Shanghai, China. Antimicrob Agents Chemother 2003, 47:2242-2248.
13. Wang M., Guo Q., Xu X., Wang X., Ye X., Wu S., et al. New plasmid-mediated quinolone resistance gene, qnrC, found in a clinical isolate of Proteus mirabilis. Antimicrob Agents Chemother 2009, 53:1892-1897.
14. Yamane K., Wachino J., Suzuki S., Kimura K., Shibata N., Kato H., et al. New plasmid-mediated fluoroquinolone efflux pump, QepA, found in an Escherichia coli clinical isolate. Antimicrob Agents Chemother 2007, 51:3354-3360.
15. Yang H., Chen H., Yang Q., Chen M., Wang H. High prevalence of plasmid-mediated quinolone resistance genes qnr and aac(6')-Ib-cr in clinical isolates of Enterobacteriaceae from nine teaching hospital in China. Antimicrob Agents Chemother 2008, 52:4268-4273.
16. Yang R., Yu R., Gao Y., Lu X. Detection of qnr gene and drug resistance in clinical isolates of Acinetobacter baumannii. Chin J Antibiot 2009, 34:747-749. (in Chinese).
17. Yang X., Zhang Y., Liang C., Fu Y., Feng Y. Study on mechanisms of plasmid-mediated quinolones resistance in Pseudomonas aeruginosa. Chin J Nosocomiol 2013, 23:2524-2526. (in Chinese).
18. Zhu Y., Yang H., Liu Y., Hu L., Cheng J., Ye Y., et al. Detection of plasmid-mediated quinolone resistance determinants and the emergence of multidrug resistance in clinical isolates of Shigella in SiXian area, China. Diagn Microbiol Infect Dis 2013, 75:327-329.